ST-01156
N/A
Report date: 2026/02/11 20:01:36
NME
Base Information
Drug NameST-01156
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[5]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesSeed Therapeutics Inc
China Registration ClassClass 1 Chemical Drug in China
Develop Information
Active CompaniesWanchun Hongji (Dalian) Pharmaceutical Co LtdSeed Therapeutics IncHumanwell Puracap (Likang) Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active Indications +[5]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A